When is the next results date for Alpa Laboratories Ltd?
2026-08-05 23:19:06The next results date for Alpa Laboratories Ltd is scheduled for 14 August 2026....
Read full news article
Alpa Laboratories Ltd is Rated Sell
2026-07-30 10:10:03Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 30 July 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news article
Alpa Laboratories Ltd is Rated Sell
2026-07-19 10:10:03Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 July 2026, providing investors with an up-to-date perspective on its performance and outlook.
Read full news article
Alpa Laboratories Ltd is Rated Sell
2026-07-07 10:10:03Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Alpa Laboratories Ltd is Rated Sell
2026-06-26 10:10:03Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Alpa Laboratories Ltd is Rated Sell
2026-06-15 10:10:04Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
Alpa Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-06-02 08:02:11Alpa Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a risky to an attractive valuation grade. This change, coupled with its current price-to-earnings (P/E) ratio of 9.85 and price-to-book value (P/BV) of 0.79, positions the stock as a potentially undervalued opportunity relative to its historical averages and peer group.
Read full news article
Alpa Laboratories Ltd is Rated Sell
2026-06-01 10:10:35Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Alpa Laboratories Q4 FY26: Profit Recovery Masks Deeper Revenue Concerns
2026-05-30 20:18:37Alpa Laboratories Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹148.00 crores, reported a net profit of ₹1.38 crores for Q4 FY26, marking a sharp recovery from the previous year's loss of ₹2.12 crores. However, the positive earnings reversal conceals troubling revenue trends, as net sales declined 21.34% year-on-year to ₹31.40 crores, raising questions about the sustainability of the company's business momentum in an otherwise buoyant pharmaceutical sector.
Read full news articleBoard Meeting Intimation for Approval Of The Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30Th June 2026
04-Aug-2026 | Source : BSEAlpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve 1. The Standalone and Consolidated unaudited Financial Results for the Quarter ended on 30th June 2026. 2. To approve the notice of 38th Annual General Meeting of the Company. 3. Any other matters as may be decided by the board of directors
Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Materiality Of Information
29-Jul-2026 | Source : BSEDisclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Announcement under Regulation 30 (LODR)-Cessation
22-Jul-2026 | Source : BSEPursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we hereby inform you that Ms. Jyoti Jain has ceased to be an Independent Director of the company upon completion of her tenurewith effect from the close of business hours on 21st july 2026.
Corporate Actions
14 Aug 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






